Adc Therapeutics SA Form 4 insider transactions

Director Ron Squarer received 40,000 restricted stock units (RSUs) as part of the annual grant under the 2019 Equity Incentive Plan.

Director Viviane Monges reports acquiring 40,000 common shares and disposing of shares, with a resulting beneficial ownership of 108,064 shares.

Redmile Group, LLC, along with related entities, acquired pre-funded warrants to purchase common shares of ADC Therapeutics SA in a public offering.

CEO of ADC Therapeutics, Ameet Mallik, sold shares to cover tax withholding obligations related to vesting and settlement of restricted share units.